Sarepta Therapeutics entered into a $600 million credit agreement with JPMorgan Chase Bank for a five-year revolving credit facility, with variable interest rates based on their leverage ratio.
AI Assistant
SAREPTA THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.